Post Menopausal clinical trials

Explore recruiting post menopausal clinical trials.

Recruiting post menopausal studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Post Menopausal trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Strategies for zoledronic acid post-denosumab discontinuation in postmenopausal osteoporosis

France

Therapeutic use (Phase IV) EU CTIS Study details

A Phase III, Randomized, Double-Blind, Parallel Group, Multicenter Study to Compare Pharmacokinetics, Pharmacodynamics, Efficacy, Safety, and Immunogenicity of BP16 Versus EU-Prolia® in Women with Post- Menopausal Osteoporosis

Latvia, Estonia, Slovakia, Hungary, Poland, Bulgaria

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase I study to evaluate the Pharmacokinetics and Safety of Letrozole LEBE in Healthy Post-menopausal Women.

Czechia, Bulgaria

Human Pharmacology (Phase I)- Other EU CTIS Study details

A phase III study comparing the concurrent versus the sequential administration of chemotherapy and aromatase inhibitors, as adjuvant treatment of post-menopausal patients with endocrine-responsive early breast cancer

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of Camizestrant in Post-menopausal Female Subjects

Bulgaria, Slovakia

Human Pharmacology (Phase I)- Other EU CTIS Study details

Randomized double blind phase 2 trial of baby exemestane versus baby tamoxifen in post-menopausal women at high risk for breast cancer. BabyTEARS (Baby Tamoxifen or Exemestane Assessment Randomized Study)

Italy, Portugal

Therapeutic exploratory (Phase II) EU CTIS Study details

Post Menopausal trials by city

Post Menopausal in Toronto Post Menopausal in Vancouver Post Menopausal in Montreal Post Menopausal in Calgary Post Menopausal in Edmonton Post Menopausal in Ottawa Post Menopausal in Winnipeg Post Menopausal in Quebec City Post Menopausal in Hamilton Post Menopausal in Kitchener Post Menopausal in London Post Menopausal in Halifax Post Menopausal in New York Post Menopausal in Los Angeles Post Menopausal in Chicago Post Menopausal in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease